Percutaneous radiofrequency thermal ablation in the management of lung tumors: Presentation of clinical experience on a series of 35 patients

Diagnostic and Interventional Radiology

Volumn 15, Issue 4, 2009, Pages 290-296

  Thanos, Loukas ^a   Mylona, Sofia ^c   Ptohis, Nikolaos ^d   Tsiouris, Spyridon ^e   Sotiropoulou, Evangelia ^b   Pomoni, Anastasia ^d   Pomoni, Maria ^d  

^a Department of Computed Tomography and Interventional Radiology ^*  (Greece)

^b KAT HOSPITAL   (Greece)

^c RED CROSS HOSPITAL   (Greece)

^d Eugenidion Hospital   (Greece)

^e UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Lung neoplasms; Neoplasm metastasis; Radiofrequency catheter ablation

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; LUNG CARCINOMA; LUNG METASTASIS; NECROSIS; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASM METASTASIS; RADIO WAVES; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74549177599     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.1828-08.2     Document Type: Article

References (37)

1. Thanos L, Mylona S, Ptohis N, Sotiropoulou E, Pomoni A, Pomoni M. Over a decade treating hepatocellular carcinoma percutaneously with radiofrequency thermal ablation. Worldwide experience. Arch Med Sci 2007; 3, 4: 293-304.
2. Smith RA, Glynn TJ. Epidemiology of lung cancer. Radiol Clin N Am 2000; 38:453-470.
3. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999; 86:1867-1876.
4. Silvestri GA, Sherman C, Williams T, Leong SS, Flume P, Turrisi A. Caring for the dying patient with lung cancer. Chest 2002; 122:1028-1036.
5. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy in stage IIIa and IIIb non-small cell lung cancer: a meta-analysis. Cancer 1995; 176:593-601.
6. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
7. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radio-frequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-2463.
8. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol 2001; 12:1135-1148.
9. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report. Radiology 2004; 230:125-134.
10. Lencioni R, Crocetti L, Cioni R, et al. Radiofrequency ablation of lung malignancies: Where do we stand? Cardiovasc Intervent Radiol 2004; 27:581-590.
11. Handy JR, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002; 122:21-28.
12. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial theurapeutic response. J Vasc Intervent Radiol 2004; 15:463-470.
13. Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006; 27:556-563.
14. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006; 30:177-183.
15. Thanos L, Mylona S, Pomoni M, et al. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg 2006; 30:797-800.
16. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-275.
17. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol 2007; 18:1264-1269.
18. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: A multicenter study in Japan. J Vasc Interv Radiol 2007; 18:393-398.
19. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644.
20. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: Results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007; 134:1306-1312.
21. Ambrogi MC, Dini P, Melfi F, Mussi A. Radiofrequency ablation of inoperable non-small cell lung cancer J Thorac Oncol 2007; 2(5 Suppl):S2-3.
22. Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. Thorac Cardiovasc Surg 2007; 134:857-864.
23. Gil-Delgado MA, Guinet F, Castaing D, et al. Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer. Am J Clin Oncol 2001; 24:101-105.
24. Zori Comba A, Blajman C, Richardet E, et al. A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients. Eur J Cancer 2001; 37:1006-1013.
25. Patz EF Jr, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR Am J Roentgenol 2000; 174:769-774.
26. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS. Positron emission tomography in the pre-treatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings Am J Clin Oncol 1996; 19:416-421.
27. Dupuy DE, Zagoria DJ, Akerlay W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in lung. AJR Am J Roentgenol 2000; 174:57-59.
28. Belfiore G, Moggio G, Tedeschi E, et al. CTguided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-A preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183:1003-1011.
29. Jin GY, Lee JM, Lee YC, Han YM, Lim YS. Primary and secondary lung malignancies treatment with percutaneous radio-frequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004; 183:1013-1020.
30. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633-646.
31. Goldberg SN, Gazelle GS, Comptom CC, McLoud TC. Radio-frequency tissue ablation in the rabbit lung. Acad Radiol 1995; 2:776-784.
32. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: Initial experience. Radiology 2004; 231:850-857.
33. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology 2003; 229:821-829.
34. Nishida T, Inoue K, Kawata Y, et al. Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. J Am College Surgeons 2002; 195:426-430.
35. Dupuy DE, Mayo-Smith WW, Abbot GF, diPetrillo T. Clinical applications of radiofrequency tumor ablation in the thorax. RadioGraphics 2002; 22:S259-S269.
36. Steinke K, Habicht JM, Thomsen S, Soler M, Jacob AL. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol 2002; 25:543-546.
37. Scudamore CH, Lee SI, Patterson EJ, et al. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177:411-417.